| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge
|
Rojas, Kristin E.
|
|
2018
|
171 |
3 |
p. 621-626
|
article
|
| 2 |
Availability of prior mammograms affects incomplete report rates in mobile screening mammography
|
Roubidoux, Marilyn A.
|
|
2018
|
171 |
3 |
p. 667-673
|
article
|
| 3 |
Breast cancer and its impact in male transsexuals
|
Nikolić, Dejan
|
|
2018
|
171 |
3 |
p. 565-569
|
article
|
| 4 |
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype
|
Yap, Yoon-Sim
|
|
2018
|
171 |
3 |
p. 719-735
|
article
|
| 5 |
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
|
Martín, M.
|
|
2018
|
171 |
3 |
p. 635-636
|
article
|
| 6 |
CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy
|
Jansen, Laura E.
|
|
2018
|
171 |
3 |
p. 701-708
|
article
|
| 7 |
Dietary supplements and fatigue in patients with breast cancer: a systematic review
|
Pereira, Paula Tâmara Vieira Teixeira
|
|
2018
|
171 |
3 |
p. 515-526
|
article
|
| 8 |
Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED)
|
Luraschi, Rosa
|
|
2018
|
171 |
3 |
p. 693-699
|
article
|
| 9 |
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03
|
Sagara, Yasuaki
|
|
2018
|
171 |
3 |
p. 675-683
|
article
|
| 10 |
Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
|
Wang, Jiayu
|
|
2018
|
171 |
3 |
p. 535-544
|
article
|
| 11 |
Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women
|
Bedi, Julie S.
|
|
2018
|
171 |
3 |
p. 759-765
|
article
|
| 12 |
Estrogen-receptor status and risk of contralateral breast cancer following DCIS
|
Stout, Natasha K.
|
|
2018
|
171 |
3 |
p. 777-781
|
article
|
| 13 |
Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial
|
Coelho, Bertha Andrade
|
|
2018
|
171 |
3 |
p. 685-692
|
article
|
| 14 |
Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings
|
Barreto, David S.
|
|
2018
|
171 |
3 |
p. 527-534
|
article
|
| 15 |
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
|
Van Swearingen, Amanda E. D.
|
|
2018
|
171 |
3 |
p. 637-648
|
article
|
| 16 |
Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review
|
Robinson, Andrew
|
|
2018
|
171 |
3 |
p. 607-620
|
article
|
| 17 |
Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence
|
Angarita, Fernando A.
|
|
2018
|
171 |
3 |
p. 545-564
|
article
|
| 18 |
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
|
Martín, M.
|
|
2018
|
171 |
3 |
p. 627-634
|
article
|
| 19 |
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
|
Sun, Yihan
|
|
2018
|
171 |
3 |
p. 657-666
|
article
|
| 20 |
Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
|
Lee, Dong-Yun
|
|
2018
|
171 |
3 |
p. 649-656
|
article
|
| 21 |
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment
|
Bauer, Emanuel C. A.
|
|
2018
|
171 |
3 |
p. 571-580
|
article
|
| 22 |
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells
|
Berthe, Audrey
|
|
2018
|
171 |
3 |
p. 581-591
|
article
|
| 23 |
Screening mammography: benefit of double reading by breast density
|
Euler-Chelpin, My von
|
|
2018
|
171 |
3 |
p. 767-776
|
article
|
| 24 |
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer
|
Brennan, Meghan
|
|
2018
|
171 |
3 |
p. 747-758
|
article
|
| 25 |
Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer
|
Kabil, Nashwa
|
|
2018
|
171 |
3 |
p. 593-605
|
article
|
| 26 |
Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study
|
Jerzak, K. J.
|
|
2018
|
171 |
3 |
p. 709-717
|
article
|
| 27 |
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
|
Kim, Ji-Yeon
|
|
2018
|
171 |
3 |
p. 737-745
|
article
|
Journal description